MICA Antibodies

Chen, Zhidan, Xia, Zhaoxia, Qing, Qiang, Haipeng, Hengxiao: "Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway." in: International immunopharmacology, Vol. 35, pp. 307-14, (2016) (PubMed).

Zanetti, Ziblat, Torres, Zwirner, Bouzat: "Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells." in: The Journal of biological chemistry, Vol. 291, Issue 32, pp. 16541-52, (2016) (PubMed).

Tyciakova, Matuskova, Bohovic, Polakova, Toro, Skolekova, Kucerova: "Genetically engineered mesenchymal stromal cells producing TNF? have tumour suppressing effect on human melanoma xenograft." in: The journal of gene medicine, (2015) (PubMed).

Shi, Li, Couturier, Yang, Guo, He, Lewis, Zhou: "Allele Specific Expression of MICA Variants in Human Fibroblasts Suggests a Pathogenic Mechanism." in: The open rheumatology journal, Vol. 9, pp. 60-4, (2015) (PubMed).

Umebayashi, Kiyota, Koya, Tanaka, Onishi, Katano, Morisaki: "An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro." in: Anticancer research, Vol. 34, Issue 8, pp. 4509-19, (2014) (PubMed).

Morisaki, Hirano, Koya, Kiyota, Tanaka, Umebayashi, Onishi, Katano: "NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors." in: Anticancer research, Vol. 34, Issue 8, pp. 4529-38, (2014) (PubMed).

Gómez-Lomelí, Bravo-Cuellar, Hernández-Flores, Jave-Suárez, Aguilar-Lemarroy, Lerma-Díaz, Domínguez-Rodríguez, Sánchez-Reyes, Ortiz-Lazareno: "Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor." in: Cancer cell international, Vol. 14, Issue 1, pp. 100, (2014) (PubMed).

Leung, Vong, Lin, Janke, Chen, Leung: "Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR? activation." in: The Journal of experimental medicine, Vol. 210, Issue 12, pp. 2675-92, (2013) (PubMed).

Andresen, Skovbakke, Persson, Hagemann-Jensen, Hansen, Jensen, Skov: "2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 188, Issue 4, pp. 1847-55, (2012) (PubMed).

Yamanegi, Yamane, Kobayashi, Kato-Kogoe, Ohyama, Nakasho, Yamada, Hata, Fukunaga, Futani, Okamura, Terada: "Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death." in: International journal of oncology, Vol. 41, Issue 1, pp. 83-91, (2012) (PubMed).